Novo Ends Phase III Kidney Disease Trial, Incurs More Than $800M Q2 Impairment Loss 0 27.06.2024 03:00 Feedity.com Novo Ends Phase III Kidney Disease Trial, Incurs More Than $800M Q2 Impairment Loss 6/27/2024 Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
